Study on factors influencing neurodevelopmental disorders in mothers and children
Official title: Platform for the Prospective Mother-child Study of the Determinants of Autism Spectrum Disorder and Neurodevelopmental Disorders Neurodevelopmental Disorders
Run by University Hospital, Montpellier · NCT05681923 · Data updated 2026-11-12
This study looks at how both genetics and the environment might affect the development of neurodevelopmental disorders like Autism Spectrum Disorder in mothers and their children.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 7320 (estimated) |
| Sponsor | University Hospital, Montpellier Academic / other |
| Locations | 1 site (Montpellier) |
| Status | Recruiting |
| Started | April 19, 2023 |
| Main results expected | March 2034 |
| Study ends | March 2034 |
| Registry record updated | June 22, 2026 |
| Trial ID | NCT05681923 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include pregnant women with at least one biological child over 24 months old, particularly those with a family history of Autism Spectrum Disorder.
✕Probably not a fit
Patients who do not have a biological child or are not pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the determinants of neurodevelopmental disorders, particularly Autism Spectrum Disorder (ASD), by examining both genetic and environmental factors. It involves collecting data through questionnaires, biospecimen collection, and neurodevelopmental assessments from pregnant mothers and their children. The study will include both high-risk and low-risk cohorts, focusing on families with a history of ASD. By understanding the multifactorial origins of these disorders, the research seeks to improve early detection and intervention strategies.
Why it matters
Potential benefit: If successful, this study could lead to better identification and intervention for children at risk of neurodevelopmental disorders.
How similar studies have gone: Other studies have shown success in identifying risk factors for neurodevelopmental disorders, but this specific approach focusing on the exposome is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
INCLUSION CRITERIA: General inclusion criteria (High risk and Low risk cohorts) Mother: * Be pregnant (single or multiple pregnancy), at least 16 weeks of amenorrhea, * Have at least one biological child of 24 months or older, * At least 18 years of age Father: * Be the biological father of the unborn child, * At least 18 years of age Unborn Child: \- Have a woman study participant as mother. Specific inclusion criteria for the High risk cohort: * Autistic sibling: refers to the biological child(ren) of the mother and/or father participating in the study and being the parent(s) of the unborn child * Be at least 24 months old and less than 18 years old, * Have a confirmed diagnosis of Autism Spectrum Disorder based on medical records. If in doubt, the SRS-2 (Social Responsiveness Scale for Adults) and PEDS-DM (Parents' Evaluation of developmental status) questionnaires will be completed. Only children with positive scores on one of these questionnaires will be included after validation of the diagnosis by an expert committee, * In case of several children with Autism Spectrum Disorder based in the siblings, only the last born will be included. Remarks: * Autism Spectrum Disorder siblings resulting from a medically assisted procreation are eligible provided that part of the genetic heritage is common to that of the mother or father of the unborn child participating in the study. * If the father does not live with the mother of the unborn child, his participation is not required and does not preclude the participation of other family members. EXCLUSION CRITERIA: General non-inclusion criteria (High risk and Low risk cohorts): Father and mother: * Unable to understand French or the study questionnaires * Participant on protective measures (guardianship or curatorship) or deprived of liberty by judicial or administrative decision, or subject to a legal protection measure * Not affiliated to a social security system * Refusal to participate. In the case of consent given for the born and unborn child, the consent must be given by the person(s) with parental authority. * Live at a distance from the recruitment center incompatible with follow-up. Specific non-inclusion criteria for the Low risk cohort: Mother and/or father of unborn child: \- Have a biological child with a diagnosis of Autism Spectrum Disorder or other neuro developmental disorder
Where it's running
-
CHU Montpellier
Montpellier, France Recruiting
Study contacts
- Study coordinator: Amaria Baghdadli, MD PhD
- Email: a-baghdadli@chu-montpellier.fr
- Phone: +33 4 67 33 63 83
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders
This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.
-
Two-week intensive brain-focused therapy program for children with neurodevelopmental and chromosomal conditions
This program will try a two-week, individualized multimodal neurorehabilitation approach for children about 4–12 years old with neurodevelopmental or chromosomal conditions to see if it improves attention, motor skills, communication, and daily functioning.
-
Social cognition testing for 8–16-year-olds with autism, ADHD, or atypical development
This project will test a multidimensional social-cognition battery in French-speaking 8–16-year-olds with autism, ADHD, or atypical neurodevelopment to see if it better identifies social processing differences.
-
Assessing motor and voice development in infants
This study is trying to see if watching videos of infants can help spot early signs of physical disabilities, especially for those at risk of Cerebral Palsy, by looking at their movement and voice development.
-
Inclusive physical activity program for adults with intellectual disabilities
This study is testing a new fitness program for adults with intellectual disabilities to see if it helps them be more active and feel better over 16 weeks.
-
Learning words through parentese in autistic children
This study is testing if using a special way of talking called parentese helps autistic children learn new words better when it's done through videos compared to live interactions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.